Modern Methods for Diagnosing the Impact of Ischemic Heart Disease on the Pathogenesis of Anemia

Uzoqova Oyjamol Narzullayevna; Jalolov Sohib Aslitdinovich; O'sarov Shohruh Abduvahob oʻgʻli

Authors

Uzoqova Oyjamol Narzullayevna Samarkand State Medical University, Assistant Professor, Department of Hematology
Jalolov Sohib Aslitdinovich Therapeutists of the Samarkand branch of the Republican Scientific Center for Emergency Medical Care
O'sarov Shohruh Abduvahob oʻgʻli Therapeutists of the Samarkand branch of the Republican Scientific Center for Emergency Medical Care

Vol. 3 No. 1 (2025): International Journal of Alternative and Contemporary Therapy

Articles

January 28, 2025

Purpose of the review: To analyze modern views on the problem of anemia in chronic heart failure (CHF), the main pathogenetic mechanisms of its formation, and the possibilities of drug correction.

Basic principles. The problem of CHF has a number of interdisciplinary aspects. One of the frequent pathologies in CHF is anemia, which exacerbates hemodynamic disorders and worsens the prognosis of patients. Understanding the mechanisms of anemia development in CHF is of great importance in choosing treatment tactics. The review discusses views on the pathogenetic mechanisms of the formation of anemia syndrome in patients with CHF. Approaches to its treatment are considered from the point of view of pathogenesis.

Conclusion: Anemia in CHF is associated with an increased risk of mortality, worsening of comorbidities, and increased functional class of heart failure, but is a potentially reversible condition.

Narzullayevna, U. O., Aslitdinovich, J. S., & oʻgʻli , O. S. A. (2025). Modern Methods for Diagnosing the Impact of Ischemic Heart Disease on the Pathogenesis of Anemia. International Journal of Alternative and Contemporary Therapy, 3(1), 74–85. Retrieved from https://medicaljournals.eu/index.php/IJACT/article/view/1490

Download Citation

Ponikowski P, Voors AA, Anker SD, Bueno H, Cleland JGF, Coats AJS et al. ESC recommendations for the diagnosis and treatment of acute and chronic heart failure 2016. Ross. cardiol. zhurn. 2017; 1(141): 7–81. [Ponikowski P., Voors AA, Anker SD, Bueno H., Cleland JGF, Coats AJS et al. ESC recommendations for the diagnosis and treatment of acute and chronic heart failure 2016. Ros. cardiol. zhurn. 2017; 1(141): 7–81. (in Russian)]

Solomakhin NI, Nakhodnova ES, Ershov VI Anemia in chronic heart failure: the role of hepcidin as a universal regulator of iron metabolism. Journal Heart. Failure. 2014; 85(4): 254–60. Solomakhin NI, Nakhodnova ES, Ershov VI Anemia in chronic heart failure: the role of hepcidin as a universal regulator of iron metabolism. Journal Heart. Insufficient. 2014; 85(4): 254–60. (in Russian)]

Marazia S., Loderini S., Magliari F., Sarullo FM, Di Mauro M. Sucrose iron supplementation may be a useful adjunct in patients with heart failure and anemia. In: Proceedings of the 5th International Multidisciplinary Course on Iron Anemia. Florence, Italy. 31 March - 1 April 2017.

Zohidova KH Selection of optimal therapy for the correction of anemia syndrome in patients with chronic heart failure. Cardiology. 2018; 58(1): 25–31. [Zohidova KX Vybor optimal'noi terapii pri korrektsii anemicheskogo sindrom u bol'nykh s khronicheskoi serdechnoi nedostatochnost'yu. Cardiology. 2018; 58(1): 25–31. (in Russian)]

Stuklov NI Iron deficiency and anemia in patients with chronic heart failure. Diet. Pharmacotherapy in cardiology. 2017; 13(5): 651–60. [Stuklov NI. Ratio. Pharmacotherapy in cardiology. 2017; 13(5): 651–60. (in Russian)]

Rudakova LE, Belyaeva Yu.B., Fatkabrarova AM, Kozina LE Anemia in chronic heart failure (according to the department of cardiology). theory. and buttocks. modern aspects of science. 2014; 6(2): 128–30. [Rudakova LE, Belyaeva Yu.B., Fatkabrarova AM, Kozina LE. Theory. I am an example. aspekti sovrem. science 2014; 6(2): 128–30. (in Russian)]

Andryev S. et al. Experience with the use of memantine in the treatment of cognitive disorders //Science and innovation. – 2023. – Т. 2. – №. D11. – С. 282-288.

Antsiborov S. et al. Association of dopaminergic receptors of peripheral blood lymphocytes with a risk of developing antipsychotic extrapyramidal diseases //Science and innovation. – 2023. – Т. 2. – №. D11. – С. 29-35.

Asanova R. et al. Features of the treatment of patients with mental disorders and cardiovascular pathology //Science and innovation. – 2023. – Т. 2. – №. D12. – С. 545-550.

Begbudiyev M. et al. Integration of psychiatric care into primary care //Science and innovation. – 2023. – Т. 2. – №. D12. – С. 551-557.

Bo’Riyev B. et al. Features of clinical and psychopathological examination of young children //Science and innovation. – 2023. – Т. 2. – №. D12. – С. 558-563.

Borisova Y. et al. Concomitant mental disorders and social functioning of adults with high-functioning autism/asperger syndrome //Science and innovation. – 2023. – Т. 2. – №. D11. – С. 36-41.

Ivanovich U. A. et al. Efficacy and tolerance of pharmacotherapy with antidepressants in non-psychotic depressions in combination with chronic brain ischemia //Science and Innovation. – 2023. – Т. 2. – №. 12. – С. 409-414.

Nikolaevich R. A. et al. Comparative effectiveness of treatment of somatoform diseases in psychotherapeutic practice //Science and Innovation. – 2023. – Т. 2. – №. 12. – С. 898-903.

Novikov A. et al. Alcohol dependence and manifestation of autoagressive behavior in patients of different types //Science and innovation. – 2023. – Т. 2. – №. D11. – С. 413-419.

Pachulia Y. et al. Assessment of the effect of psychopathic disorders on the dynamics of withdrawal syndrome in synthetic cannabinoid addiction //Science and innovation. – 2023. – Т. 2. – №. D12. – С. 240-244.

Pachulia Y. et al. Neurobiological indicators of clinical status and prognosis of therapeutic response in patients with paroxysmal schizophrenia //Science and innovation. – 2023. – Т. 2. – №. D12. – С. 385-391.

Pogosov A. et al. Multidisciplinary approach to the rehabilitation of patients with somatized personality development //Science and innovation. – 2023. – Т. 2. – №. D12. – С. 245-251.

Pogosov A. et al. Rational choice of pharmacotherapy for senile dementia //Science and innovation. – 2023. – Т. 2. – №. D12. – С. 230-235.

Pogosov S. et al. Gnostic disorders and their compensation in neuropsychological syndrome of vascular cognitive disorders in old age //Science and innovation. – 2023. – Т. 2. – №. D12. – С. 258-264.

Pogosov S. et al. Prevention of adolescent drug abuse and prevention of yatrogenia during prophylaxis //Science and innovation. – 2023. – Т. 2. – №. D12. – С. 392-397.

Pogosov S. et al. Psychogenetic properties of drug patients as risk factors for the formation of addiction //Science and innovation. – 2023. – Т. 2. – №. D12. – С. 186-191.

Prostyakova N. et al. Changes in the postpsychotic period after acute polymorphic disorder //Science and innovation. – 2023. – Т. 2. – №. D12. – С. 356-360.

Prostyakova N. et al. Issues of professional ethics in the treatment and management of patients with late dementia //Science and innovation. – 2023. – Т. 2. – №. D12. – С. 158-165.

Prostyakova N. et al. Sadness and loss reactions as a risk of forming a relationship together //Science and innovation. – 2023. – Т. 2. – №. D12. – С. 252-257.

Prostyakova N. et al. Strategy for early diagnosis with cardiovascular diseaseisomatized mental disorders //Science and innovation. – 2023. – Т. 2. – №. D12. – С. 166-172.

Rotanov A. et al. Comparative effectiveness of treatment of somatoform diseases in psychotherapeutic practice //Science and innovation. – 2023. – Т. 2. – №. D12. – С. 267-272.

Rotanov A. et al. Diagnosis of depressive and suicidal spectrum disorders in students of a secondary special education institution //Science and innovation. – 2023. – Т. 2. – №. D11. – С. 309-315.

Rotanov A. et al. Elderly epilepsy: neurophysiological aspects of non-psychotic mental disorders //Science and innovation. – 2023. – Т. 2. – №. D12. – С. 192-197.

Rotanov A. et al. Social, socio-cultural and behavioral risk factors for the spread of hiv infection //Science and innovation. – 2023. – Т. 2. – №. D11. – С. 49-55.

Rotanov A. et al. Suicide and epidemiology and risk factors in oncological diseases //Science and innovation. – 2023. – Т. 2. – №. D12. – С. 398-403.

Sedenkov V. et al. Clinical and socio-demographic characteristics of elderly patients with suicide attempts //Science and innovation. – 2023. – Т. 2. – №. D12. – С. 273-277.

Sedenkov V. et al. Modern methods of diagnosing depressive disorders in neurotic and affective disorders //Science and innovation. – 2023. – Т. 2. – №. D12. – С. 361-366.

Andreichev LA, Baleeva LV Anemia of chronic diseases. Rus. asal. journal 2014; 2:50–5. [Andreichev LA, Baleeva LV Anemia of chronic diseases. Rus. med. zhurn. 2014; 2:50–5. (in Russian) ]

Ebner N., Jankowska EA, Ponikowski P., Lainscak M., Elsner S., Sliziuk V. et al. The impact of iron deficiency and anemia on exercise capacity and outcomes in patients with chronic heart failure. Results of studies investigating comorbidities that exacerbate heart failure. Int. J. Cardiol. 2016; 205:6–12. DOI: 10.1016/j.ijcard.2015.11.178

Rukavitsyn OA Anemia of chronic diseases: selected aspects of pathogenesis and methods of correction. Onkogematologiya. 2016; 11(1): 37–46. [Rukavitsyn OA Anemia of chronic diseases: selected aspects of pathogenesis and methods of correction. Onkogematologiya. 2016; 11(1): 37–46. (in Russian)]

Caughey MC, Avery CL, Ni H, Solomon SD, Matsushita K, Wruck LM, et al. Outcomes of patients with anemia and acute decompensated heart failure with preserved and reduced ejection fraction (from the ARIC Research Society follow-up). Am. J. Cardiol. 2014; 114(12): 1850–4. DOI: 10.1016/j.amjcard.2014.09.024

Sharova EK, Babaeva LA, Padaryan SS, Soselia NN, Lukina OI, Milto AS Chronic heart failure: recommendations and actual clinical practice. Diet. pharmacotherapy in cardiology. 2016; 12(6): 631–7. [Sharova EK, Babaeva LA, Padaryan SS, Soseliya NN, Lukina OI, Mil'to AS Chronic heart failure: recommendations and real clinical practice. Ratio. Pharmacotherapy and cardiology. 2016; 12(6): 631–7. (in Russian)]

Yusuf S., Pitt B., Davis CE, Hood WB, Cohn JN. Left ventricular ejection fractions and the effect of enalapril on survival in patients with congestive heart failure. N. Engl. J. Med. 1991; 325(5): 293–302. DOI: 10.1056/NEJM199108013250501

Silverberg DS, Wexler D, Blum M, Tchebiner JZ, Sheps D, Keren G, et al. Effect of subcutaneous erythropoietin and intravenous iron on the correction of anemia in diabetic and nondiabetic patients with severe refractory congestive heart failure and chronic renal failure. Nephrol. Dial. Transplant. 2003;18(1):141–6.

Martirosyan NV, Tazhenova NN, Demidov AA Dynamics of clinical indicators depending on treatment in elderly patients with chronic heart failure with anemia. Intl. Journal of the. and. main. research. 2015; 12:827–9. [Martirosyan NV, Tazhenova NN, Demidov AA Dynamics of clinical indicators in elderly patients with chronic heart failure with anemia depending on treatment. Intl. Journal of the. and. main. research. 2015; 12:827–9. (in Russian)]

Alexander M., Grumbach K., Remy L., Rowell R., Massie BM. Congestive heart failure hospitalization and survival in California: patterns by race/ethnicity. Am. Heart J 1999;137(5):919–27.

Journal title	International Journal of Alternative and Contemporary Therapy
Initials	Int.Jour.Int.Mod.Med
Frequency	12 issues per year
Prefix DOI	10.xxxxx
Online ISSN	XXXX-XXXX
Editor In Chief	Jaung Geng Lin []
Publisher	Medical Journals Press

International Journal of Alternative and Contemporary Therapy

Modern Methods for Diagnosing the Impact of Ischemic Heart Disease on the Pathogenesis of Anemia

Authors

Downloads

Most read articles by the same author(s)

Similar Articles

Login

submenu

SocialShare

EditorialBoard

EDITORIAL BOARD

Founders

Managing Editors

Section Editors

Layout Editor

counter

Browse